Beam Therapeutics (BEAM) Accumulated Depreciation & Amortization (2019 - 2025)
Historic Accumulated Depreciation & Amortization for Beam Therapeutics (BEAM) over the last 7 years, with Q3 2025 value amounting to $88.6 million.
- Beam Therapeutics' Accumulated Depreciation & Amortization rose 3290.68% to $88.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $88.6 million, marking a year-over-year increase of 3290.68%. This contributed to the annual value of $72.1 million for FY2024, which is 4369.1% up from last year.
- As of Q3 2025, Beam Therapeutics' Accumulated Depreciation & Amortization stood at $88.6 million, which was up 3290.68% from $83.2 million recorded in Q2 2025.
- In the past 5 years, Beam Therapeutics' Accumulated Depreciation & Amortization ranged from a high of $88.6 million in Q3 2025 and a low of $10.3 million during Q1 2021
- Over the past 5 years, Beam Therapeutics' median Accumulated Depreciation & Amortization value was $39.6 million (recorded in 2023), while the average stood at $43.4 million.
- Per our database at Business Quant, Beam Therapeutics' Accumulated Depreciation & Amortization skyrocketed by 9477.58% in 2021 and then skyrocketed by 3290.68% in 2025.
- Over the past 5 years, Beam Therapeutics' Accumulated Depreciation & Amortization (Quarter) stood at $16.1 million in 2021, then skyrocketed by 87.61% to $30.2 million in 2022, then surged by 66.33% to $50.2 million in 2023, then skyrocketed by 43.69% to $72.1 million in 2024, then grew by 22.87% to $88.6 million in 2025.
- Its Accumulated Depreciation & Amortization stands at $88.6 million for Q3 2025, versus $83.2 million for Q2 2025 and $77.6 million for Q1 2025.